What is Establishment Labs's liability to issue shares to settle contract termination?

Establishment Labs (ESTA) reported liability to issue shares to settle contract termination of $0 in Q4 2025.

Establishment Labs ESTA Liability to issue shares to settle contract termination

Revenue$59.9M+44.7%

Gross profit$42.3M+52.2%

Operating income-$6.5M+61.6%

Net income-$13.4M+35.4%

EPS (diluted)-$0.45+35.7%

Cash & equivalents$68.1M-1.6%

Total debt$252.7M+12.0%

Total equity$14.8M-61.7%

Total assets$351.0M+5.3%

Operating cash flow-$4.3M+79.2%

CapEx$1.9M+146%

Free cash flow-$6.2M+71.3%

Market cap$2.57B+41.4%

Gross margin70.1%+3.7pp

Operating margin-12.4%-4.8pp

Net margin-19.1%-7.4pp

FCF margin-18.1%-6.6pp

Return on equity-164%-17.8pp

Debt / equity17.1×+11.2×

Current ratio3×-0.4×

Reported directly by Establishment Labs in its filing.

Tagged under the XBRL concept esta:NoncashOrPartNoncashLiabilityToIssueSharesToSettleContractTermination.

The official record: Establishment Labs’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →

What is Establishment Labs's liability to issue shares to settle contract termination?: Establishment Labs (ESTA) reported liability to issue shares to settle contract termination of $0 in Q4 2025.
How has Establishment Labs's liability to issue shares to settle contract termination changed year-over-year?: Establishment Labs's liability to issue shares to settle contract termination decreased by 100.0% year-over-year, from $330K to $0.